SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-22-000295
Filing Date
2022-04-21
Accepted
2022-04-21 08:35:37
Documents
56
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgbp033122form10q.htm   iXBRL 10-Q 1720533
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9500
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9479
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4225
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4096
  Complete submission text file 0001607062-22-000295.txt   5145511

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rgbp-20220331.xsd EX-101.SCH 50250
7 XBRL CALCULATION FILE rgbp-20220331_cal.xml EX-101.CAL 50176
8 XBRL DEFINITION FILE rgbp-20220331_def.xml EX-101.DEF 156791
9 XBRL LABEL FILE rgbp-20220331_lab.xml EX-101.LAB 271091
10 XBRL PRESENTATION FILE rgbp-20220331_pre.xml EX-101.PRE 226677
50 EXTRACTED XBRL INSTANCE DOCUMENT rgbp033122form10q_htm.xml XML 620819
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 22839753
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences